Quick Heal Q1 FY26 Call Transcript Released

Ashwin Thakker

18 Aug 2025 — 1 min read

Key Facts:

The provided PDF is a formal notification from Quick Heal Technologies Ltd.
It announces the availability of the Q1 FY26 investor/analyst call transcript.
The transcript itself, containing detailed sales and margin outlook, is linked externally.
Specific guidance on sales and margins cannot be extracted directly from this notification document.

Quick Heal Technologies Ltd. has released an important update for investors. This document serves as an official announcement regarding the availability of their Q1 FY26 investor/analyst call transcript. While the full financial details and forward-looking guidance require accessing the linked transcript, this communication ensures transparency and prompt access for stakeholders.

Quick Heal's Transparency in Reporting

The letter, dated August 15, 2025, from Quick Heal Technologies Ltd., confirms the release of the Q1 FY26 investor/analyst call transcript. The call was held on Friday, August 8, 2025, at 04:00 PM IST. This proactive step ensures that all stakeholders, including investors and analysts, have timely access to the discussions and insights shared during the call. The document highlights Quick Heal's commitment to clear communication by providing a direct link to the full transcript on their official website for public access.

Where to Find Quick Heal's Financial Guidance

It is important to note that the provided PDF serves as an index, directing interested parties to the comprehensive investor/analyst call transcript. While this notice confirms the availability, it does not contain the detailed financial performance metrics, future sales forecasts, or margin outlook discussed during the call. For a thorough understanding of Quick Heal's Q1 FY26 performance and forward-looking commentary, readers must refer to the full transcript provided via the company's official website link, which is crucial for in-depth analysis.

This official communication from Quick Heal Technologies Ltd. efficiently informs the market about the availability of crucial Q1 FY26 earnings insights. To gain a complete picture of Quick Heal's financial guidance, including sales and margin projections, stakeholders should access the full transcript linked within the notice. This ensures comprehensive understanding of the company's strategic direction and outlook.

Sharda Motor's Strategic Path to Future Growth

* Sales Outlook: The company anticipates continued industry growth in FY26, driven by stable macroeconomic conditions, normal monsoon, and sustained exports. It targets the non-PV segments (emissions control, off-highway, exports, light-weighting) to contribute 80% of total revenue. New light-weighting orders and temperature-controlled pipes for CEVs are expected to ramp up in

Praj Industries: Future Growth Unfolds

* Consolidated income from operations in Q1 FY'26 stood at Rs. 6.4 billion, down from Rs. 6.99 billion in Q1 FY'25. * Profit before tax (PBT) for Q1 FY'26 was Rs. 96.09 million, a significant decrease from Rs. 788.8 million in Q1

ECOS Mobility: Guiding Towards Sustained Profitability

Key Facts on Outlook: * Full-year Revenue Growth Guidance: 15%-18%, with confidence to achieve the higher end. * Full-year EBITDA Margin Guidance: 13%-15%, targeting around 14% on operating business, excluding one-off provisions. * Strategic Investments: Significant focus on technology upgrades (RentNet, CabDrive Pro) and fleet expansion. * Planned Annual CAPEX: Expected to

Rossell Techsys Powers Future Growth and Profits

* Outlook for Sales: Anticipates substantial, multi-fold revenue growth for the full year FY26, building on a near-doubling in Q1 FY26 (INR45.60 Cr to INR88.29 Cr YoY). Holds confirmed Purchase Orders (POs) of over INR700 crores, with approximately INR150 crores executable in FY26, and a strategic order book of